Testosterone use is rising among women seeking menopause relief, but doctors warn of dosing challenges, limited evidence and safety concerns.
Testosterone therapy is gaining traction among women seeking relief from low sexual desire and menopause-related symptoms. However, doctors are raising concerns about inconsistent dosing, limited scientific evidence and the lack of FDA-approved testosterone products specifically designed for women in the United States.
The growing demand has brought renewed attention to how testosterone is prescribed, what benefits it can realistically provide and whether patients are receiving adequate guidance on its use.
According to a September 19 report by Fox News, women seeking testosterone therapy are encountering insurance denials, complicated prescribing workarounds and uncertainty over appropriate doses.
The issue has also drawn federal attention, with the U.S. Food and Drug Administration (FDA) convening a public workshop to examine the evidence, safety and research gaps surrounding testosterone treatment for menopausal women.
Why More Women Are Turning to Testosterone
Testosterone is commonly associated with male health, but it also plays a role in women’s bodies. Interest in testosterone therapy has grown as women seek solutions for low libido and other symptoms they associate with menopause.
Some patients report improvements in sexual desire and quality of life. However, medical experts caution that evidence supporting testosterone for broader menopause-related symptoms remains limited.
According to physicians cited by Fox News, social media discussions and personal recommendations have also contributed to rising interest in the treatment, sometimes creating expectations that extend beyond what clinical research currently supports.
The distinction is important because testosterone is not an established treatment for every symptom associated with menopause.
Doctors Flag Dosing Challenges and Treatment Uncertainty
One of the central concerns is the lack of an FDA-approved testosterone formulation specifically for women in the United States.
As a result, physicians may prescribe FDA-approved testosterone products intended for men at substantially lower doses or turn to compounded formulations.
These approaches can create practical challenges involving dose measurement, insurance coverage and treatment consistency.
Dr. Kudzai Dombo, a board-certified obstetrician-gynecologist and menopause specialist, told Fox News that clinicians sometimes have to navigate considerable uncertainty when determining how to proceed with treatment.
The absence of standardized female-specific products can also leave patients facing higher out-of-pocket costs and complicated medication routines.
In some cases, patients may struggle to determine whether a treatment is working as expected, highlighting the need for careful medical supervision and follow-up.
What Does the Evidence Say About Testosterone Therapy?
Current evidence-based guidance supports testosterone therapy for a specific condition known as hypoactive sexual desire disorder (HSDD), which involves persistently low sexual desire associated with distress.
Research has found benefits for some postmenopausal women with this condition.
However, evidence remains insufficient to establish testosterone as a reliable treatment for fatigue, mood changes, cognitive concerns, sleep problems or general age-related changes in well-being.
This distinction has become increasingly important as testosterone is discussed as a potential solution for a broader range of menopause symptoms.
Medical experts have also highlighted the need for additional research into long-term safety, appropriate dosing and potential adverse effects.
FDA Scrutiny Puts Women’s Hormone Treatment in Focus
The Ida’s September 2026 public workshop reflects growing attention to testosterone therapy for women as demand increases and physicians navigate off-label prescribing.
Reuters reported that testosterone prescriptions for women increased 146% between January 2023 and July 2026, underscoring the rapid expansion of its use.
Regulators and medical experts are examining whether additional research and standardized, female-specific formulations could improve access while addressing concerns about safety and dosing.
Potential side effects of testosterone therapy include acne, increased facial or body hair and changes in the voice. Some safety questions, including concerns about long-term cardiovascular and breast cancer risks, remain unresolved.
What Women Should Know Before Considering Testosterone
The growing popularity of testosterone therapy highlights the importance of distinguishing established medical uses from treatments that are still being investigated.
Although testosterone may benefit some women experiencing HSDD, it is not a proven universal solution for menopause symptoms or aging-related concerns.
Women considering hormone treatment should discuss their symptoms, medical history, potential benefits and risks with a qualified healthcare professional.
As researchers and regulators continue examining testosterone therapy, the central challenge remains balancing patient demand with reliable evidence, consistent dosing and appropriate medical oversight.
Also read: Gruesome Images Could Uncover Wider Serial Killer Network
